QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:GL

Globe Life (GL) Stock Price, News & Analysis

$66.74
+1.74 (+2.68%)
(As of 04:37 PM ET)
Today's Range
$64.50
$67.66
50-Day Range
$49.17
$128.39
52-Week Range
$38.95
$132.00
Volume
3.13 million shs
Average Volume
1.87 million shs
Market Capitalization
$6.28 billion
P/E Ratio
6.62
Dividend Yield
1.44%
Price Target
$126.44

Globe Life MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
89.5% Upside
$126.44 Price Target
Short Interest
Healthy
2.99% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.21
Upright™ Environmental Score
News Sentiment
0.14mentions of Globe Life in the last 14 days
Based on 29 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.10%
From $11.60 to $12.54 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.97 out of 5 stars

Finance Sector

12th out of 843 stocks

Life Insurance Industry

2nd out of 20 stocks

GL stock logo

About Globe Life Stock (NYSE:GL)

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

GL Stock Price History

GL Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Globe Life Target of Unusually Large Options Trading (NYSE:GL)
7 Top Dividend Stocks Set for 200%+ Gains by 2028
Why Globe Life Stock Soared Today
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Globe Life Insurance Review 2024
Globe Life (GL) Scheduled to Post Earnings on Monday
Evercore ISI Cuts Globe Life (NYSE:GL) Price Target to $75.00
Globe Life (NYSE:GL) Shares Gap Up to $49.17
Globe Life (NYSE:GL) Upgraded to Buy at StockNews.com
Globe Life (NYSE:GL) Price Target Cut to $132.00
5 Investors Betting Big on Globe Life (GL) Stock
See More Headlines
Receive GL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globe Life and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/1 Dividend
1/04/2024
Dividend Payable
2/01/2024
Last Earnings
2/07/2024
Ex-Dividend for 5/1 Dividend
4/04/2024
Today
4/19/2024
Next Earnings (Confirmed)
4/22/2024
Dividend Payable
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Life insurance
Sub-Industry
N/A
Employees
3,636
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$126.44
High Stock Price Target
$160.00
Low Stock Price Target
$75.00
Potential Upside/Downside
+91.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

Net Income
$970.76 million
Pretax Margin
21.92%

Debt

Sales & Book Value

Annual Sales
$5.45 billion
Cash Flow
$15.62 per share
Book Value
$47.68 per share

Miscellaneous

Free Float
92,617,000
Market Cap
$6.22 billion
Optionable
Optionable
Beta
0.69
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

GL Stock Analysis - Frequently Asked Questions

Should I buy or sell Globe Life stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globe Life in the last year. There are currently 5 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GL shares.
View GL analyst ratings
or view top-rated stocks.

What is Globe Life's stock price target for 2024?

9 Wall Street research analysts have issued 1 year price objectives for Globe Life's stock. Their GL share price targets range from $75.00 to $160.00. On average, they anticipate the company's stock price to reach $126.44 in the next twelve months. This suggests a possible upside of 89.5% from the stock's current price.
View analysts price targets for GL
or view top-rated stocks among Wall Street analysts.

How have GL shares performed in 2024?

Globe Life's stock was trading at $121.72 at the beginning of 2024. Since then, GL stock has decreased by 45.2% and is now trading at $66.74.
View the best growth stocks for 2024 here
.

Are investors shorting Globe Life?

Globe Life saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,750,000 shares, an increase of 19.6% from the March 15th total of 2,300,000 shares. Based on an average daily trading volume, of 775,900 shares, the days-to-cover ratio is currently 3.5 days. Currently, 3.0% of the company's stock are sold short.
View Globe Life's Short Interest
.

When is Globe Life's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024.
View our GL earnings forecast
.

How can I listen to Globe Life's earnings call?

Globe Life will be holding an earnings conference call on Tuesday, April 23rd at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 786-697-3501 with passcode "GLOBE LIFE INC".

How were Globe Life's earnings last quarter?

Globe Life Inc. (NYSE:GL) announced its earnings results on Wednesday, February, 7th. The company reported $2.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.73 by $0.15. The company earned $1.42 billion during the quarter, compared to the consensus estimate of $1.40 billion. Globe Life had a net margin of 17.82% and a trailing twelve-month return on equity of 24.25%. Globe Life's quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.24 earnings per share.
Read the conference call transcript
.

How often does Globe Life pay dividends? What is the dividend yield for Globe Life?

Globe Life announced a quarterly dividend on Monday, March 18th. Investors of record on Friday, April 5th will be paid a dividend of $0.24 per share on Wednesday, May 1st. This represents a $0.96 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date is Thursday, April 4th. This is a boost from the stock's previous quarterly dividend of $0.23.
Read our dividend analysis for GL
.

Is Globe Life a good dividend stock?

Globe Life (NYSE:GL) pays an annual dividend of $0.96 per share and currently has a dividend yield of 1.52%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.52%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GL will have a dividend payout ratio of 7.66% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for GL.

What ETFs hold Globe Life's stock?
What guidance has Globe Life issued on next quarter's earnings?

Globe Life updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share guidance of 11.300-11.800 for the period, compared to the consensus EPS estimate of 11.430. The company issued revenue guidance of -.

What other stocks do shareholders of Globe Life own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globe Life investors own include AT&T (T), AbbVie (ABBV), Chevron (CVX), International Business Machines (IBM), Intel (INTC), Johnson & Johnson (JNJ), Exxon Mobil (XOM), JPMorgan Chase & Co. (JPM), Coca-Cola (KO) and RTX (RTX).

Who are Globe Life's major shareholders?

Globe Life's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.49%), Pensioenfonds Rail & OV (0.30%), Sumitomo Mitsui Trust Holdings Inc. (0.26%), Welch Group LLC (0.05%), IMC Chicago LLC (0.00%) and Alaska Permanent Fund Corp (0.02%). Insiders that own company stock include Charles E Adair, Cheryl Alston, Christopher Todd Moore, David Kendall Carlson, Dolores L Skarjune, Frank M Svoboda, Frank M Svoboda, Gary L Coleman, James Eric Mcpartland, James Matthew Darden, Jane Buchan, Jason A Harvey, Jennifer Allison Haworth, John Henry Rogers, Jr, Kenneth J Matson, Larry M Hutchison, Melissa Jane Buchan, Michael Clay Majors, Michael Shane Henrie, Pierre Beaurang, Robert Brian Mitchell, Robert W Ingram, Robert W Ingram, Steven John Dichiaro, Steven Kelly Greer and Terren S Peizer.
View institutional ownership trends
.

How do I buy shares of Globe Life?

Shares of GL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:GL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners